Company / SG&A per Share
CAPRICOR THERAPEUTICS, INC. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.41
FY2025
5-year range
$0.31 / $0.41
FY2021-FY2025
Trend
+26.6%
vs FY2024
Sector context
#174 of 210
Health Care
What the data says
CAPRICOR THERAPEUTICS, INC.'s sg&a per share of $0.41 is lower than 83% of companies in the Health Care sector (FY2025). SG&A per Share returned to growth in FY2025 after 2 years of decline, reaching $0.41.
Based on SEC 10-K filings.
0.41 in FY2025 with a 5-year CAGR of +8.9%.
Remained stable around $0.41 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -0.0%
- 5-Year CAGR
- +8.9%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 210This company $0.41 Sector average $40.71
▼
-99.0% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 26.6% year-over-year.
- Ranks #174 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.41 | +26.6% |
| FY2024 | $0.33 | -20.7% |
| FY2023 | $0.41 | -0.5% |
| FY2022 | $0.41 | +31.3% |
| FY2021 | $0.31 | +16.8% |
| FY2020 | $0.27 | -82.9% |
| FY2019 | $1.57 | +900.0% |
| FY2018 | $0.16 | -13.3% |
| FY2017 | $0.18 | -21.4% |
| FY2016 | $0.23 | -14.3% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026